Bimatoprost
24 NDCs across 8 manufacturers|19 Generic,5 Brand
Bimatoprost is used to treat open-angle glaucoma, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Mar 16, 2001, and the first generic was approved Dec 1, 2014. FDA's Orange Book lists 3 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $656 million on Bimatoprost across 1.5 million claims for 357,000 beneficiaries.
Bimatoprost is available as 24 NDCs from 8 manufacturers (19 generic, 5 brand), with NADAC prices from $4.21 to $103.11 per ML — the most expensive product costs about 25× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
24
19G / 5B
Manufacturers
8
competing in market
Price Spread
$4.21 – $103.11
per ML
7d Activity
avg -2.0% WoW · of 24 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Allergan, Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Prostaglandin Analog class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
8 manufacturers producing BIMATOPROST(1 pricing outlier)
Frequently Asked Questions
What is Bimatoprost used to treat?
Bimatoprost is used to treat open-angle glaucoma, per the National Library of Medicine's MED-RT classification.
When did Bimatoprost become available as a generic?
FDA approved the first generic Bimatoprost (ANDA) on Dec 1, 2014. The Orange Book currently lists 3 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Bimatoprost?
In 2024, Medicare Part D spent $656 million on Bimatoprost across 1.5 million claims for 357,000 beneficiaries.
How many Bimatoprost products are on the market?
The Bimatoprost drug market contains 24 NDCs from 8 manufacturers — 19 generic and 5 brand products.
What is the price range for Bimatoprost?
NADAC reference prices for Bimatoprost range from $4.2071 to $103.1086 per ML — the most expensive product costs about 25× the cheapest.
Is generic Bimatoprost cheaper than brand?
The average generic NADAC for Bimatoprost is $10.5997 per ML, versus $76.3257 for brand-labeled products — brand versions average about 7.2× the generic price.
Which manufacturers make Bimatoprost?
8 manufacturers list Bimatoprost in NADAC. Ranked by number of NDCs, the largest are Allergan, Inc. (5), Alembic Pharmaceuticals Inc. (4), Micro Labs Limited (3), Aurobindo Pharma Limited (3), Somerset Therapeutics, LLC (3).
How has the price of Bimatoprost changed recently?
Over the past 7 days, 2 Bimatoprost NDCs rose and 22 fell, with a market-wide average change of -2.0%.